导师姓名： 金光植 专业代码： 100214
性别： 男 专业名称： 肿瘤学
培养单位： 附属同仁医院 三级学科/
专业领域：
导师类型： 博士生导师 专业学位导师：
联系方式： jgzhi@hotmail.com
邮编： 邮箱地址： jgzhi@hotmail.com

研究方向 (点击浏览详细信息)
肿瘤标记物在诊断，预后，治疗中的应用研究
肝胆肿瘤标记物的临床应用和分子机制研究

社会任职

科研项目 项目编号项目名称课题来源起止年月批准经费承担职责
TR2019rc07 引进人才启动经费 同仁医院 2020-09~2022-08 20万元 课题负责人
** RAN蛋白调控PGM1核表达缺失在肝细胞癌发生发展中的机制研究 国家自然科学基金-面上项目 2020-01~2023-12 55万元 课题负责人
** SUOX基因调控对肝癌细胞生物学功能的影响机制及其在化疗敏感性中的作用 国家自然科学基金-面上项目 2015-01~2018-12 72万元 课题负责人
** PGM1基因在肝细胞癌中的抑癌功能及分子机制 国家自然科学基金-青年项目 2013-01~2015-12 23万元 课题负责人

学术论文 作者论文标题期刊名出版年卷期页码
Wen-Long Yu,* Guanzhen Yu,* Hui Dong,* Ke Chen,* Jun Xie,* Hua Yu, Yuan Ji, Guang-Shun Yang, Ai-Jun Li,# Wen-Ming Cong,# Guang-Zhi Jin# （通讯作者） Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinoma J Gastroenterol 2020 55(12):1171-1182
Yu H, Wang H, Dong W, Cao ZY, Li R, Yang C, Cong WM, Dong H#, Jin GZ# （通讯作者） The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma PeerJ 2020 8:e8454
Cai QY, Jiang JH, Jin RM, Jin GZ# （通讯作者）, Jia NY# The clinical significance of lipopolysaccharide binding protein in hepatocellular carcinoma Oncol Lett 2020 19(1):159-166
Yu H, Wang H, Xu HR, Zhang YC, Yu XB, Wu MC, Jin GZ# （通讯作者）, Cong WM# Overexpression of MTHFD1 in hepatocellular carcinoma predicts poorer survival and recurrence Future Oncol 2019 15(15):1771-1780
Chen K, Jin R, Shi C, Ge R, Hu L, Zou Q, Cai Q, Jin G# （通讯作者）, Wang K# The prognostic value of Niemann-Pick C1-like protein 1 and Niemann-Pick disease type C2 in hepatocellular carcinoma J Cancer 2018 9(3):556-563
Jin GZ*, Zhang Y*, Cong WM*, Wu X, Wang X,Wu S, Wang S, Zhou W, Yuan S, G Hong, Yu G, Yang W Phosphoglucomutase 1 Inhibits Hepatocellular Carcinoma Progression by Regulating Glucose Trafficking Plos Biology 2018 e**
Jin H*, Wang C*, Jin G* （共同第一作者）, Ruan H, Gu D, Wei L, Wang H, Wang N, Arunachalam E, Zhang Y, Deng X, Yang Chen Yang, Xiong Y, Feng H, Yao M, Fang J, Gu J, Cong W, Qin W Regulator of Calcineurin 1 Gene Isoform 4, Downregulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Growth of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1 Gastroenterology 2017 153(3):799-811
Zhang Y*, Tao X*, Jin G* （共同第一作者）, Jin H, Wang N, Hu F, Luo Q, Shu H, Zhao F, Yao M, Fang J, Cong W, Qin W, Wang C A Targetable Molecular Chaperone Hsp27 Confers Aggressiveness in Hepatocellular Carcinoma Theranostics 2016 6(4):558-70
Jin GZ*, Dong W*, Dong H*, Yu H, Chen J, Yu WL, Li AJ, Cong WM, Wu MC The Diagnostic and Prognostic Value of MRP8/MRP14 in Intrahepatic Cholangiocarcinoma Oncotarget 2015 6(36):39357-64
Yu G*, Yu W*, Jin G* （共同第一作者）, Xu D, Chen Y, Xia T, Yu A, Fang W, Zhang X, Li Z, Xie K PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma Mol Cancer 2015 14(1):193
Wang C*, Jin G* （共同第一作者）, Jin H*, Wang N, Luo Q, Zhang Y, Gao D, Jiang K, Gu D, Shen Q, Huo X, Hu F, Ge T, Zhao F, Chu W, Shu H, Yao M, Cong W, Qin W Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma Oncotarget 2015 6(5):2903-16
Luo Q*, Wang C*, Jin G* （共同第一作者）, Gu D, Wang N, Song J, Jin H, Hu F, Zhang Y, Ge T, Huo X, Chu W, Shu H, Fang J, Yao M, Gu J, Cong W1, Qin W LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway Carcinogenesis 2015 36(10):1201-12
Jin GZ*, Dong H*, Yu WL*, Li Y, Lu XY, Yu H, Xian ZH, Dong W, Liu YK, Cong WM, Wu MC A Novel Panel of Biomarkers in Distinction of Small Well-Differentiated HCC from Dysplastic Nodules and Outcome Values BMC cancer 2013 13:161
Yu H*, Jin GZ* （共同第一作者）, Liu K*, Dong H, Yu H, Duan JC, Li Z, Dong W, Cong WM, Yang JH Twist2 is a valuable prognostic biomarker for colorectal cancer World Journal of Gastroenterology 2013 19(15):2404-11
Jin GZ*, Yu WL*, Dong H*, Zhou WP, Gu YJ, Yu H, Yu H, Lu XY, Xian ZH, Liu YK, Cong WM, Wu MC SUOX is a Promising Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma J Hepatol 2013 59(3):510-7
Jin GZ*, Li Y*, Cong WM*, Yu H, Dong H, Shu H, Liu XH, Yan GQ, Zhang L, Zhang Y, Kang XN, Guo K, Wang ZD, Yang PY, Liu YK iTRAQ-2DLC-ESI-MS/MS Based Identification of a New Immunohistochemical Biomarkers for Classification of Dysplastic Nodules and small Hepatocellular Carcinoma J Proteome Res 2011 10(8):3418-28